DiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Treatment OutcomeDrug Therapy, CombinationDouble-Blind MethodCost-Benefit AnalysisTime FactorsQuality-Adjusted Life YearsModels, EconomicCombined Modality TherapyRandomized Controlled Trials as TopicSingle-Blind MethodProspective StudiesFollow-Up StudiesClinical Trials as TopicExercise TherapyQuality of LifePatient ComplianceRisk AssessmentDose-Response Relationship, DrugRandom AllocationChemotherapy, AdjuvantUnited StatesRisk FactorsRetrospective StudiesMass ScreeningSeverity of Illness IndexBreast NeoplasmsDietary SupplementsPatient Education as TopicCross-Over StudiesBlood PressureSurvival AnalysisAngiotensin-Converting Enzyme InhibitorsDisease-Free SurvivalOutcome Assessment (Health Care)Drug Administration ScheduleAntineoplastic Combined Chemotherapy ProtocolsRecurrenceExerciseSurvival RateAnalysis of VarianceSensitivity and SpecificityDietInsurance BenefitsQuestionnairesPregnancyMultivariate AnalysisAntineoplastic AgentsPrognosisDisease Models, AnimalCohort StudiesHealth Benefit Plans, EmployeeInsurance, Pharmaceutical ServicesPatient SelectionCost SharingSocial SecurityEvidence-Based MedicineDecision MakingHealth Care CostsNeoplasmsAge FactorsEmployer Health CostsDrug CostsResearch DesignGreat BritainEligibility DeterminationDecision Support TechniquesPilot ProjectsInsurance CoverageCosts and Cost AnalysisPractice Guidelines as TopicKaplan-Meier EstimateInformed ConsentInsurance, DisabilityPatient SatisfactionChronic DiseaseMyocardial InfarctionInfant, NewbornCost SavingsHealth Knowledge, Attitudes, PracticeCooperative BehaviorStrokeProgram EvaluationManaged Care ProgramsProportional Hazards ModelsCardiovascular DiseasesRiskModels, EconometricPredictive Value of TestsCost ControlAltruismDisease ProgressionConservation of Natural ResourcesHydroxymethylglutaryl-CoA Reductase InhibitorsModels, TheoreticalReproducibility of ResultsHearing AidsPlacebosHealth PolicyNeoplasm StagingHealth Promotion